Correlation Engine 2.0
Clear Search sequence regions
Bookmark Forward

QuickView for l carnitine (compound)


PubChem
Name: Carnitine
PubChem Compound ID: 10535083
Description: Constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias.
Molecular formula: C7H15NO3
Molecular weight: 167.177 g/mol
DrugBank
Identification
Name: Carnitine
Name (isomeric): DB00583
Drug Type: small molecule
Description: Constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias.
Synonyms:
(S)-Carnitine; (-)-Carnitine; (-)-L-Carnitin; Vitamin BT; 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium; Carnitine
Brand: Karnitin, Nicetile, Carnitor
Category: Nootropic Agents, Vitamin B Complex, Metabolite, Nutraceutical, Vitamins (Vitamin B Complex)
CAS number: 541-15-1
Pharmacology
Indication: For treatment of primary systemic carnitine deficiency, a genetic impairment of normal biosynthesis or utilization of levocarnitine from dietary sources, or for the treatment of secondary carnitine deficiency resulting from an inborn error of metabolism such as glutaric aciduria II, methyl malonic aciduria, propionic acidemia, and medium chain fatty acylCoA dehydrogenase deficiency. Used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias. Parenteral levocarnitine is indicated for the prevention and treatment of carnitine deficiency in patients with end-stage renal disease.
Pharmacology:
Levocarnitine is a carrier molecule in the transport of long chain fatty acids across the inner mitochondrial membrane. It also exports acyl groups from subcellular organelles and from cells to urine before they accumulate to toxic concentrations. Lack of carnitine can lead to liver, heart, and muscle problems. Carnitine deficiency is defined bioch...
show more »
Mechanism of Action:
Levocarnitine can be synthesised within the body from the amino acids lysine or methionine. Vitamin C (ascorbic acid) is essential to the synthesis of carnitine. Levocarnitine is a carrier molecule in the transport of long chain fatty acids across the inner mitochondrial membrane. It also exports acyl groups from subcellular organelles and from cel...
show more »
Absorption: Absolute bioavailability is 15% (tablets or solution).
Protein binding: None
Biotransformation: Major metabolites include trimethylamine N-oxide and [3H]-gamma-butyrobetaine.
Half Life: 17.4 hours (elimination) following a single intravenous dose.
Toxicity: LD50 > 8g/kg (mouse, oral). Adverse effects include hypertension, fever, tachycardia and seizures.
Affected organisms: Humans and other mammals

Targets


Transporters